Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study.
about
Brain resuscitation in the drowning victimCreatine for women in pregnancy for neuroprotection of the fetusAllopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathyPharmacologic neuroprotective strategies in neonatal brain injuryStem cell therapy for neonatal hypoxic-ischemic encephalopathyOxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies.Chronic allopurinol treatment during the last trimester of pregnancy in sows: effects on low and normal birth weight offspringWhich neuroprotective agents are ready for bench to bedside translation in the newborn infant?Oxidative stress in fetal distress: potential prospects for diagnosis.New antioxidant drugs for neonatal brain injury.Baby STEPS: a giant leap for cell therapy in neonatal brain injuryPregnant womens' concerns when invited to a randomized trial: a qualitative case control study.Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical careADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURYTreatment advances in neonatal neuroprotection and neurointensive care.Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep.Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury.An interdisciplinary fetal/neonatal neurology program.Antioxidant therapies: a potential role in perinatal medicine.Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.Curcumin attenuates hypoxic-ischemic brain injury in neonatal rats through induction of nuclear factor erythroid-2-related factor 2 and heme oxygenase-1.Maternal-to-fetal allopurinol transfer and xanthine oxidase suppression in the late gestation pregnant rat.Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: Is it a gender question?Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy.A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep.Management of Hypoxic-ischemic Encephalopathy.Ultrasound evaluation of cortical brain development in fetuses with intrauterine growth restriction.Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia.Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour.Behavioral and neurodevelopmental outcome of children after maternal allopurinol administration during suspected fetal hypoxia: 5-year follow up of the ALLO-trial
P2860
Q23909719-4F6C6130-15CA-46FC-8F13-FC30C01D89B1Q24187191-DDAE4989-EBC8-49E3-B57F-6A7679D2CD0EQ24202191-9408A5AA-53E3-4FBE-A139-303320AF2891Q26852406-0D83F178-FDB7-47FE-9B33-4C084D861CF0Q27003906-30041854-B608-4D06-A42B-3E39191BF5A7Q28073954-84895B31-C1A0-4DAA-B1D6-9E2B5758F81FQ28539019-E5E68097-7919-4C04-9F55-F8711AF4BB81Q33723452-D4687F5F-9669-4DF1-B72B-CE2197B6D94FQ34185780-CBAC5C3A-2579-4BBB-9958-11BED70B9486Q35037632-7304D0F8-1991-49FF-BE70-4C6BC108B137Q35051518-7C25CA8A-22B8-4BEA-8B3F-E70326296304Q35765096-470C1B77-1372-4E9E-8D26-8363D9188A11Q36117876-2012A81C-7DDE-4E82-B050-53543B837C7CQ36737627-8600401B-0641-41BC-81B7-D25200960229Q37131984-76384C6E-9DDD-4679-8924-74DC0AC67DBCQ37430173-9006DE4B-0525-44BA-826C-5C2E64CB5EA4Q37575742-9588F129-10CD-4C89-BC41-EFA0F363AD1FQ37976090-0E2B8C9C-3214-41E1-B7F2-A0CC40FA809BQ37980082-2888334A-1C25-4901-A7B0-428D485F5E8AQ37989302-7DB31D05-B68D-4B29-A624-4C4B928709C0Q38760911-B4733EB3-B43D-4390-A8B7-B9F598A0BF2AQ41116829-6F631244-2C0B-4A0F-BEB9-5CC598B63166Q42094540-4EE72C92-ADA9-4634-88CE-92E7B4E3A4E6Q42361461-E5414ADA-55EF-4844-B83B-47AD906F2DC5Q46970216-67030997-2326-4405-B895-3273EE164F5EQ48187354-53D14E8A-45B5-4417-9A49-157FFE089CA6Q48456116-3A70CD3F-82D7-47C4-9B02-37B585156FD4Q48612801-04CC40F1-B3A6-4899-A633-20DD66954F92Q48857103-7FC1B650-9342-4234-841D-02CA2B454242Q50482094-1EBA11B5-1540-4321-8DEA-1DC635F13E16Q58715900-A656C713-BD0E-4DDC-8855-0B856BF75676
P2860
Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antenatal allopurinol for redu ...... controlled multicenter study.
@ast
Antenatal allopurinol for redu ...... controlled multicenter study.
@en
Antenatal allopurinol for reduction of birth asphyxia induced brain damage
@nl
type
label
Antenatal allopurinol for redu ...... controlled multicenter study.
@ast
Antenatal allopurinol for redu ...... controlled multicenter study.
@en
Antenatal allopurinol for reduction of birth asphyxia induced brain damage
@nl
prefLabel
Antenatal allopurinol for redu ...... controlled multicenter study.
@ast
Antenatal allopurinol for redu ...... controlled multicenter study.
@en
Antenatal allopurinol for reduction of birth asphyxia induced brain damage
@nl
P2093
P2860
P921
P356
P1476
Antenatal allopurinol for redu ...... controlled multicenter study.
@en
P2093
A W Danilo Gavilanes
Anjoke J M Huisjes
Arie F Bos
Ben Willem J Mol
Carin M A Rademaker
Christine Willekes
Claudia A van Meir
Corrie J W F M Jacobs
Cuno S P M Uiterwaal
Frank van Bel
P2860
P2888
P356
10.1186/1471-2393-10-8
P577
2010-02-18T00:00:00Z
P5875
P6179
1044508941